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Focal adhesion kinase and Src mediate 
microvascular hyperpermeability caused by 
fibrinogen- γC- terminal fragments 
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Z�aq{wan Yani5, A＀ezanfta M0 Arqnte 3, Hani Yani3, Petet T0 Pe＀uqn 6, Mae￿ J0 Yw3*
,
3 Derattoent qh Swtiet{, Wn�xetu�t{ qh Sqwth H＀qt�fa Mqtuan� Eq＀＀eie qh Mef�e�ne, Vaora, HN, Wn�tef Stateu 
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☯ Vheue awthqtu eqntt�bwtef eqwa＀＀{ tq th�u wqt￿0 
* oww3Bwuh0efw 
Abstract 
Qb�eet�xeu
Ye rtex�qwu＀{ terqttef o�etqxauew＀at ＀ea￿aie teuw＀t�ni htqo h�bt�nqien/ γ eha�n E/teto�na＀ 
rtqfwetu (γE) qeewttef x�a a ThqA/ferenfent oeehan�uo0 Vhe qb�eet�xe qh th�u utwf{ wau
tq hwtthet e＀we�fate the u�ina＀�ni oeehan�uo b{ wh�eh γE �nfweeu enfqthe＀�a＀ h{retretoe/
ab�＀�t{0 S�nee �t �u ￿nqwn that γE b�nfu anf aet�xateu enfqthe＀�a＀ αxβ5, a ttanuoeobtane
�nteit�n teeertqt �nxq＀xef �n �nttaee＀＀w＀at u�ina＀�ni oef�atef b{ the t{tqu�ne ￿�naueu HAM 
anf Ste, we h{rqtheu�zef that γE a＀tetu enfqthe＀�a＀ batt�et hwnet�qn b{ aet�xat�ni the HAM/
Ste rathwa{ ＀eaf�ni tq �wnet�qn f�uuqe�at�qn anf ThqA ft�xen e{tqu￿e＀eta＀ utteuu/h�bet 
hqtoat�qn0
Methqfu anf teuw＀tu
Wu�ni �nttax�ta＀ o�etqueqr{ qh tat oeuentet�e o�etqxeuue＀u, we uhqw �neteauef ezttaxaua/
t�qn qh r＀auoa rtqte�n (a＀bwo�n) teuw＀t�ni htqo γE afo�n�uttat�qn0 Kn aff�t�qn, ear�＀＀at{ h＀w�f
h�＀ttat�qn eqehh�e�ent (M he) �nf�eatef γE/�nfweef e＀exatef ＀wni xauew＀at retoeab�＀�t{0 Hwtthet/ 
oqte, γE feeteauef ttanuenfqthe＀�a＀ batt�et teu�utanee �n a t�oe/ferenfent anf fque/
te＀atef hauh�qn �n ew＀twtef tat ＀wni o�etqxauew＀at enfqthe＀�a＀ ee＀＀u (TNMVGEu), aeeqora/
n�ef b{ �neteauef HAM/Ste rhqurhqt{＀at�qn feteet�qn b{ weutetn b＀qt0 Gzret�oentu w�th
rhatoaeq＀qi�ea＀ �nh�b�t�qn qt iene u�＀ene�ni qh HAM uhqwef u�in�h�eant＀{ tefweef γE/
�nfweef a＀bwo�n anf h＀w�f ＀ea￿aie aetquu o�etqxeuue＀u, utteuu/h�bet hqtoat�qn, VG/eafhet�n
t{tqu�ne rhqurhqt{＀at�qn, anf �ortqxef γE/�nfweef enfqthe＀�a＀ batt�et f{uhwnet�qn, �nf�eat/
�ni the �nxq＀xeoent qh HAM �n γE oef�atef h{retretoeab�＀�t{0 Eqoratab＀e teuw＀tu wete
hqwnf when Ste wau tatietef �n a u�o�＀at oannet, hqwexet �nh�b�t�qn qh HAM rtexentef Ste 
aet�xat�qn, uwiieut�ni that HAM �u wrutteao qh Ste �n γE/oef�atef h{retretoeab�＀�t{0 Kn 
aff�t�qn, γE/�nfweef e{tqu￿e＀eta＀ utteuu/h�bet hqtoat�qn wau attenwatef fwt�ni �nh�b�t�qn qt
u�＀ene�ni qh theue t{tqu�ne ￿�naueu, eqneqo�tant＀{ w�th ThqA �nh�b�t�qn0 
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Eqne＀wu�qn 
Vhe HAM/Ste rathwa{ eqntt�bwteu tq γE/�nfweef o�etqxauew＀at batt�et f{uhwnet�qn, �wnet�qn
rtqte�n rhqurhqt{＀at�qn anf f�uqtian�zat�qn �n a oannet that �nxq＀xeu ThqA anf utteuu/ 
h�bet hqtoat�qn0 
Knttqfwet�qn 
When severe injury results in bleeding, fibrinogen, a soluble protein consisting of α, β and γ 
polypeptide pairs, is converted at the wound into fibrin by thrombin [1]. The proteolysis of 
fibrin is coupled with its breakdown into fibrin degradation products (FDPs), which includes 
a D-dimer and soluble C-termini of the α, β and γ chains [1]. Elevated plasma levels of FDPs 
have been documented in numerous pathological conditions, such as congestive heart failure 
[2], ischemic strokes [3], and myocardial infarctions [4]. Of all the soluble fibrinogen mono- 
mers, the C-terminus of the γ chain is of specific interest due to its reactivity imparted by a cal- 
cium binding site, polymerization pocket and cross-binding site. This reactive region allows 
for surface receptor binding and stimulates fibrin cross-linking [5]. Our previous study identi- 
fied the C-terminal fragment of fibrinogen gamma chain (γC) as a mediator of microvascular 
leakage via association with αvβ3 integrin receptor in RhoA-dependent pathway [5], which 
suggested the participation of the fibrinolysis pathway in other cellular functions besides coag- 
ulation. However, the mechanism behind fibrinogen γC microvascular hyperpermeability is 
not fully understood. 
Endothelial cells line the internal vascular surface and in conjunction with the underlying 
extracellular matrix (ECM) creates an important interface responsible for maintaining vascular 
barrier function [6, 7]. The integrity of this barrier is largely dependent on junction proteins, 
which are connected to the F-actin cytoskeleton via linker proteins [6, 7]. Proinflammatory 
mediators, including interlukin-1 (IL-1), tumor necrosis factor (TNF), vascular endothelial 
growth factor (VEGF), and activated neutrophils are capable of causing endothelial barrier 
dysfunction [8, 9]. The underlying mechanism involves cytoskeleton contraction, adherens 
junction (AJ) dissociation, and focal adhesion disruption [9]. Impaired barrier function results 
in microvascular leakage and edema, which are hallmark events in the progression of severe 
trauma, sepsis, multiple organ failure, and other inflammatory disease conditions [6, 9]. 
Tethering of the endothelial monolayer to the ECM is mediated by focal adhesion com- 
plexes, which are regulated by various signaling molecules and play a critical role in mediating 
adhesion, contraction and permeability [6, 10, 11]. Within this dynamic cellular environment, 
focal adhesion kinase (FAK) catalyzes various downstream reactions leading to focal adhesion 
assembly and integrin linkage allowing the endothelial monolayer to attach to the extracellular 
matrix [11–13]. FAK is mainly regulated through tyrosine phosphorylation at residues Y925, 
Y397 and Y576/577 [12]. Activation of these sites leads to focal adhesion formation, integrin 
binding, cell contraction, intercellular gap formation and consequential microvascular barrier 
dysfunction [12–14]. Numerous inflammatory mediators have been reported to activate FAK 
and cause increased transendothelial permeability [10, 15]. Our laboratory and others have 
shown that inhibition of FAK attenuates vascular hyperpermeability in response to VEGF [8, 
14], activated neutrophils [13], and advanced glycation end products (AGEs) [16].The interac- 
tion between FAK and other tyrosine kinases, such as c-Src, a non-receptor tyrosine kinase 
belonging to the Src family kinases (SFKs), has been well established over the past decades [12, 
15, 17, 18]. Studies have shown that Src induces vascular permeability through focal adhesion 
PNQS QPG ~ httru<//fq�0qti/3203593/�qwtna＀0rqne0225395; Art�＀ 52, 2222 2 / 23
PLOS ONE HAM/Ste eqntt�bwteu tq h�bt�nqien γE �nfweef o�etqxauew＀at ＀ea￿aie 
complex interactions and phosphorylation of Vascular Endothelial (VE)-cadherin, which 
results in dissociation of cadherin-catenin-actin AJ complexes [16]. Previous studies have 
demonstrated that Src inhibition attenuates TNFα-induced pulmonary vascular hyperperme- 
ability via restoring VE-cadherin integrity [19]. Blocking the Src pathway can also reduce β- 
catenin phosphorylation and neutrophil-induced vascular hyperpermeability [20]. 
It is well documented that FAK and Src activity are heavily associated with the RhoA path- 
way [12, 21]. Activation of FAK and Src increase phosphorylation of cytoskeletal proteins, 
including p190RhoGAP, a key regulator of Rho activity [21, 22]. Activation of small GTPases 
RhoA play a central role in regulating actin dynamics, and RhoA is directly responsible for F- 
actin stress fiber formation [23]. The close correlation between F-actin stress fiber formation 
and loss of endothelial monolayer integrity in response to hyperpermeability factors has been 
reported [24, 25]. 
Despite the increasing evidence that FDPs contribute to inflammation [3–5], physiological 
mechanism of the disease development remains to be decided due to complexity of fibrino- 
gen’s multi-domain structure and its diverse cellular targets. In our previous study, we notated 
γC stimulated integrin-mediated barrier dysfunction by targeting αvβ3 [5]. Considering that 
the role of FAK and Src are well documented in vascular leakage and the development of 
inflammatory diseases [12, 13, 26, 27], and its association with αvβ3 integrin signaling was 
reported [5], FAK and Src have emerged as potential mediators to transmit the γC barrier 
response. In the current study, we sought to determine if FAK and/or Src activity drives γC 
microvascular leakage. Assessing the physiological impact of targeting these kinases may pro- 
vide new information for developing therapeutic strategies in improving severe trauma- 
induced vascular hyperpermeability.
Matet�a＀u anf oethqfu 
Reagents and supplies 
A detailed list of reagents, supplies, and vendors is provided in S1 Table. 
Intravital microscopy 
Protocol instructions were followed as previously described [5]. Rats (males weighing 200–300 
g) were anesthetized with an intramuscular injection of urethane at 1.75 g/kg. Right carotid 
artery was cannulated and connected to a pressure transducer for continuous blood pressure 
monitoring by a DigiMed Blood Pressure Analyzer (Micro-Med; Lousiville, KY). The left jugu- 
lar vein was cannulated for infusion of drugs and/or solutions. A midline laparotomy was per- 
formed, and a section of the proximal ileum mesentery was exteriorized over the optical stage 
for microscopic observation. The exteriorized mesentery was constantly superfused with 37˚C 
lactated Ringer’s Injection USP (Baxter Healthcare; Deerfield, IL). The body temperature was 
maintained at 37˚C using a heating pad (Fine Science Tools; North Vancouver, BC) and ani- 
mals received continuous intravenous infusion of lactated Ringer’s at 0.04 mL/min/kg of body 
weight to replenish fluid loss during the experiment. 
Rat mesenteric microcirculation was examined using a Nikon Eclipse E600FN Microscope 
equipped with a Photometrics Cascade 512F digital camera under a 10X working distance 
objective (Technical Instruments, Burlingame, CA). The diameter of resistance arterioles and 
postcapillary venules were measured. For measurement of plasma protein extravasation, rats 
were given an intravenous bolus of FITC-albumin at 100 mg/kg of body weight, followed by 
continuous infusion at 0.15 mg/kg/min to maintain a constant plasma tracer concentration. 
Mesentery preparation was equilibrated for 30 minutes to establish a steady baseline, prior to 
image collection. Fluorescent images were analyzed using Simple PCI version 5.3.1 software 
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(Compix Imaging Systems; Cranberry Township, PA). Fluorescence intensity was measured 
from windows positioned inside (Ii) and outside (Io) a selected venule. Albumin transvascular 
flux was determined from the ratio of the transmural fluorescence intensity difference to the 
initial intravascular intensity normalized to background intensity, and calculated as 1-(Ii- Io)/ 
Ii [28]. 
Capillary filtration coefficient (Kfc) measurement 
Wild-type (WT) C57BL6 mice (weighing 25–30 g) were used for isolated perfused lung experi- 
ments and Kfc measurement analysis, following the protocol described [29]. The isolated-per- 
fused mouse lung was instrumented with arterial cannula at the base of the pulmonary artery 
and left atrial cannula, and ventilated (186 breaths/min) and perfused with 3% albumin-krebs 
37˚C solution at a constant rate of 2 mL/min for 20 minutes to equilibrate. All preparations 
were mechanically ventilated and arterial and venous pressures were monitored continuously 
throughout the experiment. Perfusion pressure of lung preparations varied from 7 to 12 cm3 
H2O, and remained within ~1 cm
3 H2O of the initial value over the course of an experiment. 
The capillary filtration coefficient (Kfc) was measured to determine pulmonary microvascu- 
lar permeability to liquid, as described [29]. After perfused lungs were equilibrated for 20 min- 
utes, γC was infused for 5 minutes via cannulated pulmonary artery at a rate of 0.2 mL/min, at 
a final concentration of 10 μg/mL with or without pre-perfused FAK inhibitor (PF-573228, 
1 μM), or Src inhibitor (PP2, 10 μM) for 30 minutes. Lung wet weight changed in a ramplike 
fashion, emulating net fluid extravasation. At the end of the experiment, lungs were dissected 
free of non-pulmonary tissue, and lung dry weight was determined in order to calculate Kfc, 
which was measured as slope of recorded weight change normalized to pressure change and 
lung dry weight. 
Animals 
The protocols using rats (Sprague-Dawley) and mice (C57BL6 wild type) were approved by 
the Institutional Animal Care and Use Committee (IACUC) at the University of South Florida 
and were in accordance with the National Institutes of Health Guides for the Care and Use of 
Laboratory Animals and the guidelines of the Animal Welfare Act published by the US 
National Institutes of Health (NIH Publication ON. 85–23, revised 1996). 
Cell culture 
Rat Lung Microvascular Endothelial Cells (RLMVECs) were cultured in gelatin-coated 100 
mm dishes, 6-well plates, ECIS assays or chambered glass microwells. Cells were incubated in 
a 5% CO2 humidified incubator at 37˚C to reach confluence 2–3 days prior to experiments. 
Recombinant fibrinogen C-terminal domains 
Recombinant γC fragment (residue 151–411, 30 kD) was produced as previously described 
[5]. Its cDNA was cloned into the pET21a vector and overexpressed in E. coli. Then, the 
recombinant protein was renatured through urea step gradient and refolded by dialysis. The 
refolding buffer was exchanged for PBS, followed by detoxification, in which the final product 
was suspended in endotoxin-free PBS. 
Gene silencing 
Transfection with FAK or Src siRNA duplexes (see Supplementary Materials and Methods) 
were conducted by electroporation using Nucleofector™ II Device (Lonza, Amaxa™ 
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Biosystems; Cologne, Germany) as previously described [30]. Briefly, cells were trypsinized, 
pelleted, and resuspended in Basic Endothelial Nucleofector Solution containing siRNA 
duplexes [0.4 μM]. Immediately after electroporation with program T-011, cell suspension 
was mixed with 500 μL of pre-warmed MCDB-131 complete medium and seeded on 100 
mm dishes, 6-well plates, or ECIS arrays. Endothelial cells were treated as designed 48 hours 
post-transfection. 
Transendothelial Electrical Resistance (TER) 
Endothelial barrier function was determined by measuring transendothelial resistance using 
an electric cell-substrate impedance sensing (ECIS; Z theta; Applied Biophysics, Inc.) system 
[31]. RLMVECs were subcultured onto the ECIS electrode arrays at 1 × 105 cell/cm2, and 
allowed to reach two-days post-confluence. A 1 V, 4,000 Hz alternating signal was connected 
serially through a 1 MO resistor between the two electrodes to supply a constant current of 
1 μA. The in-phase voltage (proportional to resistance) and the out-of-phase voltage (propor- 
tional to capacitive resistance) were measured and analyzed with ECIS_Core software 
(v1.2.210.1 Mac; Applied BioPhysics, Inc.). ECIS tracings of TER are presented as either resis- 
tance (Ohms) or normalized change in resistance, i.e. normalized to baseline resistance at time 
of stimulus with gamma C peptides. 
Rho activity assay 
Rho activation in endothelial cells was assessed using a Rho-GTP pulldown assay kit as previ- 
ously described [25]. Briefly, confluent endothelial cells were serum deprived in EBM medium 
with 0.5% FBS for 4 hours prior to treatment. Cells were washed twice with TBS and lysed in 
Mg2� lysis/wash buffer [MLB: 25 mM HEPES (pH 7.5), 150 mM NaCl, 1% Igepal CA-630, 10 
mM MgCl2, 1 mM EDTA, 10% glycerol, 10 μg/mL leupeptin, 25 mM NaF, and 1 mM vana- 
date] with protease/phosphatase inhibitor cocktail. Cell lysates were incubated with Rhotekin- 
Rho-binding domain on a rotator at 4˚C for 1 hour. The beads were washed 3 times with MLB 
and incubated in 2×SDS sample buffer at 95˚C for 5 minutes to elute protein. Active RhoA 
was then separated by SDS-PAGE and detected by immunoblotting. 
Immunocytochemistry 
RLMVECs were cultured on gelatin-coated glass bottom microwells to confluency. Immuno- 
cytochemistry was performed per standard protocols and as we have previously described 
[32]. Briefly, after appropriate treatments, cells were fixed with 4% PFA and permeabilized 
with 10% donkey serum containing 0.05% Triton X-100. After blocking, cells were immunos- 
tained with VE-cadherin (VE-cad) and β-catenin (β-cat) antibodies at 4˚C overnight and 
appropriate fluorescent conjugated antibodies for 1 hour at RT. F-actin was stained by Alexa 
Fluor 647-phalloidin (2,000 U/mL, 20 minutes) at room temperature. Slides were mounted in 
Vectashield containing DAPI and imaged with a FLUOVIEW FV1000 confocal laser scanning 
microscope (Olympus) using a 60X objective (UPLFLN 60X OI NA:1.25). Confocal micro- 
graph stacks were analyzed and processed with Imaris (Bitplane) or NIH ImageJ. As an indica- 
tor of adherens junction integrity (Fig 6), intensity analyses of VE-cadherin and β-catenin 
were measured at cell-cell junctions and quantified in three different ways: 1) VE-cad/β-cat 
colocalization—Pearson’s correlation coefficient was derived from their scatterplots (Fig 6B); 
2) the total surface area of gaps between cells within the RLMVEC monolayer (Fig 6D); or 3) 
as disruptions in pixel-to-pixel tracings of positive VE-cadherin staining at cell-cell contacts 
(Fig 6E). As an indicator of stress fiber formation, phalloidin staining was quantified by either 
PNQS QPG ~ httru<//fq�0qti/3203593/�qwtna＀0rqne0225395; Art�＀ 52, 2222 5 / 23 
PLOS ONE HAM/Ste eqntt�bwteu tq h�bt�nqien γE �nfweef o�etqxauew＀at ＀ea￿aie 
total intensity within the micrograph (Fig 7B); or intensity of cytoplasmic and perinuclear 
ROI’s (Fig 7C). 
Western blotting 
RLMVECs were grown to confluence in MCDB-131 complete medium, treated as designed, 
and lysed in lysis buffer [20 mM Tris (pH 7.4), 2.5 mM EDTA, 1% Triton X-100, 1% deoxy- 
cholic acid, 0.1% SDS, 100 mM NaCl, 10 mM NaF, 1 mM Na3VO4] containing protease/phos- 
phatase inhibitor cocktail. Lysates were collected and clarified by centrifugation at 13,000 g for 
20 minutes, prior to SDS-PAGE, and transferring proteins to PVDF membranes. Blots were 
then blocked using 5% BSA in TBST (TBS containing 0.5% Tween20) for 1 hour, followed by 
overnight incubation at 4˚C on a rocker in 1:1000 dilution of the primary antibody of interest. 
The following day, membranes were washed three times for 5 minutes each with TBST, the 
membrane was incubated with a corresponding horseradish peroxidase (HRP) conjugated sec- 
ondary antibody for 1 hour at room temperature. Membranes were washed after secondary 
incubation three times for 5 minutes each with TBST, and protein bands were visualized by 
chemiluminescence. 
Immunoprecipitation 
RLMVECs were washed once with PBS and lysed in IP lysis buffer (20 mM Tris-Cl (pH 7.5), 
150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 
1mM β-glycerol phosphate, 1 mM Na3VO4) containing protease/phosphatase inhibitor cock- 
tail. The lysates were clarified by centrifugation at 14,000 rpm for 10 minutes, and superna- 
tants were incubated in 1 μg of corresponding antibody with gentle rocking overnight at 4˚C. 
The following morning, samples were incubated with protein A-Sepharose suspension at 4˚C 
for 1 hour. The beads were washed 3 times in the IP lysis buffer, heated in 2x SDS sample 
buffer at 95˚C for 5 minutes, and resolved on SDS-PAGE followed by immunoblotting. 
Statistical analyses 
All statistics were performed using GraphPad Prism (version 6.0f). Unless otherwise noted, all 
data represent the mean and s.e.m. Unpaired, two-tailed, T-tests were used for pairwise com- 
parisons and One-way ANOVA with Tukey’s post-hoc analysis was used for comparisons of 3 
or more groups. α was set at 0.05 a priori for statistical significance.
Teuw＀tu 
γC-induced microvascular leakage and endothelial barrier dysfunction 
We began our study by testing the effect of γC on cultured RLMVECs. Transendothelial elec- 
trical resistance (TER) was obtained using ECIS arrays, after RLMVECs were plated and 
grown to 2-day post-confluence. We found that ˚C induces barrier dysfunction in a dose- 
related manner (Fig 1C). Using 10 μg/mL as an effective dosage, the impact of ˚C on rat 
mesenteric microvascular leakage was tested. Using intravital microscopy, FITC-albumin flux 
was observed after perfusion of ˚C or vehicle control into mesenteric microcirculation. ˚C 
treatment increased microvascular leakage of albumin throughout the time intervals of 5, 10 
and 30 minutes (Fig 1A). The albumin transvascular flux was recorded as control vs. ˚C treat- 
ment (Fig 1B) for the given time intervals. In vivo and in vitro experiments denoted the harm- 
ful effect of γC on the endothelial barrier. 
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Fig 1. γC induces microvascular hyperpermeability and endothelial barrier dysfunction. Rat proximal ileum mesenteric microcirculation was exteriorized on 
microscopic platform. FITC-Albumin was allowed to equilibrate through circulation prior to treatment with γC (10 μg/mL). (A) Leakage of γC was observed at 5 
minutes and continued throughout the recorded duration of 30 minutes, representative images taken at 0, 5, 10, and 30 minutes are shown, scale bar = 40 μm. (B) 
Quantitative analysis showing increased albumin transvascular flux across mesenteric microvessels with γC treatment vs. control. Data represent means ± s.e.m. ￿ 
indicates p > 0.05 vs. timepoint 0, (n = 4). Primary rat lung microvascular endothelial cell (RLMVEC) monolayers grown in ECIS arrays and treated with γC dosages of 
5, 10, and 20 μg/mL while transendothelial resistance (TER) measurements were recorded (C) Representative TER tracings are shown and peak TER reduction 
representing barrier dysfunction was calculated by subtracting the lowest resistance following γC addition to media. Embedded bar graphs represent the mean peak 
change and s.e.m. Groups with the same letter are not significant from each other (p @ 0.05), (n = 4).
https://doi.org/10.1371/journal.pone.0231739.g001 
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FAK inhibition attenuates γC-induced microvascular leakage and barrier 
dysfunction 
Since FAK has be implicated in integrin-mediated barrier dysfunction [10] and previous 
experiments denote the binding of γC to integrin αvβ3 [5], we sought to deduce the role of 
FAK in γC-induced microvascular hyperpermeability. Rat ileum mesenteric microvessels were 
pretreated with pharmacological inhibitor (PF573228 at 1 μM for 30 minutes) prior to γC or 
vehicle control treatment and FITC-albumin flux was measured via intravital microscopy (Fig 
2A and 2B). The capillary filtration coefficient (Kfc) was measured via perfusion of a cannu- 
lated mouse pulmonary artery with γC (10 μg/mL) with or without pre-treatment of FAK 
inhibitor (PF573228, 1 μM, 30 minutes). Data show that FAK inhibition reduces γC-induced 
microvascular hyperpermeability (Fig 2C). After growing RLMVECs on ECIS arrays to 2-day 
post-confluence, TER was measured and showed that treatment with PF573228 attenuates γC- 
induced barrier dysfunction (Fig 2D). Immunoblotting shows that γC induces phosphoryla- 
tion of FAK Y397 in a dose-related manner (Fig 2E). Using γC dose of 10 μg/mL, since it 
caused a significant drop in barrier function using TER measurement (Fig 1C), we demon- 
strated an increase in phosphorylation of FAK (Y397) that was temporally consistent with γC- 
induced barrier dysfunction (Fig 2F). All western blot analysis showed no noticeable difference 
in total FAK expression. Taken together, these data suggest that γC-induced endothelial bar- 
rier dysfunction and vascular hyperpermeability are dependent on FAK activity. 
Src inhibition attenuates γC-induced microvascular leakage and barrier 
dysfunction 
Once activated through phosphorylation of Y416, Src can phosphorylate many proteins 
involved in regulation of the endothelial barrier [20, 26, 33], therefore we asked whether Src 
activation was involved in γC-elicited microvascular leakage. Analysis of albumin transvascu- 
lar flux shows quantification of γC-induced microvascular leakage is attenuated in response to 
Src inhibition with PP2 (Fig 3A and 3B). The capillary filtration coefficient (Kfc) was measured 
via perfusion of a cannulated mouse pulmonary artery with γC (10 μg/mL) with or without 
pre-treatment of Src inhibitor (PP2, 10 μM, 30 minutes). Results show that Src inhibition 
reduces γC-induced microvascular hyperpermeability (Fig 3C). In vitro studies show Src phar- 
macological inhibitor (PP2) attenuated γC barrier dysfunction, using TER as a measurement 
of endothelial barrier function (Fig 3D). Immunoblotting shows that γC increases phosphory- 
lation of Src (Y416) in a dose-related manner (Fig 3E). Using γC [10 μg/mL] treatment, we 
determined that γC-induced Src phosphorylation at Y416 is temporally consistent with FAK 
phosphorylation and barrier dysfunction (Fig 3F). All western blot analyses showed no notice- 
able difference in total Src expression. Taken together, these data imply that Src activation was 
necessary for γC-elicited barrier dysfunction and microvascular hyperpermeability. 
γC-induced Src activation requires FAK 
To confirm that gene silencing of FAK and Src warranted similar effects on γC induced barrier 
dysfunction as pharmacological inhibition (shown in Figs 2 and 3), we transfected RLMVECs 
monolayers with two sets of pooled siRNA sequences for both FAK and Src to ensure the effec- 
tiveness of FAK or Src knockdown before the treatment with γC (10 μg/mL) and quantifica- 
tion of the peak TER reduction using ECIS assays. The information of these pooled siRNAs is 
detailed in Supplementary Material. Gene silencing of FAK and Src attenuated γC-induced 
barrier dysfunction (Fig 4A–4F). Given that FAK acts as an upstream regulator of Src [7, 34, 
35], we investigated whether FAK is also an upstream regulator of Src in γC-induced barrier 
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Fig 2. FAK inhibition reduces γC-induced microvascular hyperpermeability and barrier dysfunction. Rat proximal ileum mesenteric microvessels were exteriorized 
on microscopic platform, equilibrated with FITC-Albumin, pretreated with FAK inhibitor (PF573228, 1 μM) for 30 minutes prior to 10 μg/mL γC treatment. A) 
Visualization of rat ileum microvessels treated with FAK inhibitor prior to γC treatment show reduced microvascular leakage at 5, 10, and 30 minutes when compared 
to γC only treatment (Fig 1A). Images are representative of four individual experiments. Scale bar = 40 μm. B) Quantitative analysis of albumin transvascular flux at 10 
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min was compared with control and γC only treatment values obtained from Fig 1A, (n = 4). C) While perfusing isolated mouse lung preparations, capillary filtration 
coefficients (Kfc) were measured and demonstrated elevated fluid filtration in response to γC which was reduced when pretreated with PF573228, (n = 4). D) RLMVEC 
monolayers in ECIS arrays were treated with PF573228 (1 μM) prior to addition of γC (10 μg/mL). Representative ECIS tracing of normalized change in TER are shown 
with a bar graph insert of the mean peak changes, (n = 4). E-F) RLMVECs were treated with γC dosages of 0, 5, 10, and 20 μg/mL (E) and 10 μg/mL at indicated time 
points of 0, 1, 5, 20, 30 minutes (F) followed by detection of total FAK and phospho-FAK Y397 specific antibodies. Blots and average optical densities are representative 
of three independent experiments (n = 3). Bar graphs represent the means ±s.e.m. Groups with the same letter are not significant from each other (p @ 0.05).
https://doi.org/10.1371/journal.pone.0231739.g002 
dysfunction. RLMVEC monolayers were transfected with FAK siRNA or pretreated with 
PF573228 before application of γC (10 μg/mL). Western blot analysis found that inhibition of 
FAK via pharmacological inhibitor PF573228 or FAK siRNA greatly attenuated γC-induced 
increase in Src phosphorylation of Y416 (Fig 4G and 4H). All western blot analysis showed no 
noticeable difference in total Src expression. 
FAK and Src activation mediate γC-mediated Adherens Junction (AJ) 
dissociation 
In order to determine the mechanism by which the barrier is being disturbed, we sought to 
establish a relationship between γC-induced barrier dysfunction and junctional proteins. As 
indicated by immunoprecipitation of both VE-cadherin (VE-cad) and β-catenin (β-cat), we 
found that γC caused VE-cad/β-cat uncoupling which was attenuated by inhibition of FAK 
and Src (Fig 5A and 5B). Additionally, γC was found to induce VE-cad phosphorylation of res- 
idue Y658 in a dose-related manner (Fig 5C). Pharmacological inhibition of FAK and/or Src 
using PF573228 and PP2, respectively, reduced γC-induced VE-Cadherin phosphorylation of 
Y658 (Fig 5D and 5E). Furthermore, the cultured ECs with reduced level of FAK by siRNA 
treatment displayed attenuated phosphorylation of VE-Cadherin Y658 (data not shown). 
Immunocytochemistry experiments further demonstrate the effect of γC on junctional pro- 
tein uncoupling and gap formations in RLMVECs (Fig 6). Using immunofluorescence confo- 
cal microscopy showed that γC induces junctional protein dissociation, as indicated by 
decreased VE-cad and β-cat colocalization that was attenuated by FAK or Src pharmacological 
inhibition (Fig 6A and 6B). Additionally, 3D-representation of the VE-cad junctional staining 
(Fig 6C and 6D) demonstrates that Src and FAK inhibition rescues γC-induced gap formations 
at cell-cell borders, which was quantified as total surface area of gaps (Fig 6D), or non-continu- 
ous staining around cell borders (Fig 6E). 
FAK and Src in RhoA-dependent γC-induced endothelial barrier 
dysfunction 
Our final experimental finding deduced the relationship between γC and GTP-Rho. To inves- 
tigate whether FAK and/or Src activation influences cytoskeleton arrangement, F-actin mor- 
phology was revealed by AF-647 conjugated phalloidin staining and confocal microscopy (Fig 
7A–7C). γC (10 μg/mL) treatment heightened F-actin stress fiber formation with dense and 
rough outlines in the cytoplasm and perinuclear regions of RLMVECs. Pharmacological inhi- 
bition of FAK and Src, using PF573228 (1μM) and PP2 (10μM) respectively, reduced γC- 
induced stress fiber formation (Fig 7A–7C). Active RhoA, GTP-RhoA, is known to induce 
cytoskeleton rearrangement [36, 37], and since FAK and Src are implicated in cell contractility 
mechanisms regulated by RhoA [21, 38], we tested whether inhibition of FAK and/or Src 
effected γC-induced RhoA activation. Using a RhoA GTPase pull-down assay as an indicator 
of RhoA activation, in cultured RLMVECs we demonstrated that γC induced activation of 
RhoA was attenuated by FAK or Src inhibition (Fig 7D–7F). To further elucidate the role of 
FAK and Src, we showed that siRNA knockdown of FAK and Src independently reduced γC- 
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Fig 3. Src inhibition reduces γC-induced microvascular hyperpermeability and barrier dysfunction. Rat proximal ileum mesenteric microvessels were exteriorized 
on microscopic platform, equilibrated with FITC-Albumin, pretreated with Src inhibitor (PP2, 10 μM) for 30 minutes prior to γC (10 μg/mL). A) Visualization of rat 
ileum microvessels treated with PP2 prior to γC treatment show reduced microvascular leakage at 5, 10, and 30 minutes when compared to Fig 1A γC only treatment. 
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Images are representative of four individual experiments. B) Quantitative analysis of albumin transvascular flux (10 mins) shown in Fig 3A compared with control and 
γC only treatment values obtained from Fig 1A, demonstrate that PP2 attenuates γC effect on albumin transvascular flux by approximately 50% (n = 4). C) Using 
isolated perfused mouse lung preparations, demonstrates elevated capillary filtration coefficient (Kfc) in response to γC and an approximate 35% reduction when 
pretreated with PP2, (n = 4). D) RLMVECs were grown on ECIS arrays, pretreated with PP2 (10 μM) and then γC (10ug/mL). Peak TER reduction representing barrier 
dysfunction was calculated showing an approximate 50% attenuation of γC response with Src inhibition (n = 4). E-F) RLMVECs were treated with γC dosages of 0, 5, 
10, and 20 μg/mL and 10 μg/mL at indicated time points of 0, 1, 5, 20, 30 minutes followed by detection of total Src and Phospho-Src Y416 specific antibodies. γC- 
induced phosphorylation of Src (Y416) in a dose-related manner and peak Src phosphorylation (Y416) was seen at 10 minutes (E) Blots and average optical densities are 
representative of three independent experiments, (n = 3). Bar graphs represent the means ±s.e.m. Groups with the same letter are not significant from each other 
(p @ 0.05).
https://doi.org/10.1371/journal.pone.0231739.g003 
mediated activation of GTP-Rho (Fig 7D). All blot analysis showed no noticeable difference in 
total Rho expression. 
D�uewuu�qn 
Although the roles of FAK and Src have been implicated in endothelial barrier dysfunction 
caused by various inflammatory mediators [10, 20, 26, 39], their specific effects in FDP-γC- 
induced vascular leakage have not been reported. Within this study we demonstrate 1) γC 
induces microvascular hyperpermeability in vivo and endothelial barrier dysfunction in cul- 
tured endothelial cells; 2) The activation of FAK and Src contribute to the endothelial barrier 
alteration in response to γC; 3) FAK activates Src through an increase of phosphorylation at 
residue Y416; 4) γC-induced FAK and/or Src activity promotes AJ dissociation; and 5) FAK 
and/or Src regulate γC-induced RhoA activation and F-actin stress fiber formation. To the 
best of our knowledge, our study provides the first line of evidence demonstrating cellular sig- 
naling mechanisms involved in γC-induced microvessel hyperpermeability. Increase of circu- 
lating D-dimer, one of the major FDPs has been clinically associated with thrombotic 
disorders and systemic inflammation [4, 40]. Whether more specific biomarkers, such as γC 
can be used as a predictor of trauma severity warrants further investigation. In our study, the 
effect of γC on permeability in the animal model produced a slower initial response but a lon- 
ger duration in comparison to the effect in cultured endothelial cells. The observation was con- 
sistent with our previously published data [5]. The longer time course of hyperpermeability in 
vivo is likely contributed by the complexity of vascular tissue structure and the impact of blood 
circulation including delayed contact between γC and endothelium, involvement of glycocalyx 
and participation of plasma proteins, blood cells that could produce a longer hyperpermeabil- 
ity effect. We further complement cell culture techniques with animal models to provide direct 
evidence for the involvement of FAK/Src signaling in endothelial barrier hyperpermeability 
caused by γC. Moreover, immunoprecipitation assay, immunofluorescence labeling, and 
immunoblotting demonstrate that γC-mediated FAK and Src activation is capable of catalyz- 
ing downstream pathways leading to AJ disassembly, and endothelial cytoskeleton contract- 
ibility to induce endothelial barrier dysfunction. Currently, some FAK and Src inhibitors have 
been tested to examine their roles in cell migration and angiogenesis for the beneficial effect in 
cancer treatment [33, 41]. In our study, we provide a new perspective of these inhibitors, 
which has the potential to rescue endothelial barrier dysfunction in post severe trauma. 
FAK is a well-established key-regulator of Src and RhoA pathways, the activation of which 
lead to cell-cell junction loosening, cytoskeleton contractility, and vascular hyperpermeability 
[12, 20, 34]. Several lines of evidence have demonstrated that inhibition of FAK effectively 
blocks endothelial barrier dysfunction [7, 13, 14]. For instance, it was reported that blocking 
FAK activation by FRNK (FAK-related non-kinase) reduced activated neutrophil-induced vas- 
cular leakage [13]. FAK inhibitor (PF573228) has been shown to attenuate AGES-induced and 
Tys (analog of sphingosine 1-phosphate)-induced TER elevation [16, 35]. While both FAK 
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Fig 4. siRNA knockdown of FAK and Src reduces γC-induced barrier dysfunction and FAK inhibition reduces phosphorylation of Src (Y416). 
RLMVECs were grown on ECIS arrays and transfected as indicated with two independent pools of siRNA duplexes targeting FAK, siFAK(1) and siFAK 
(2), or Src, siSrc(1) and siSrc(2), prior to treatment with γC (10 μg/mL). A) ECIS tracings comparing the effect of FAK knockdown with siFAK(1) and 
siFAK(2) on γC-mediated barrier dysfunction (n = 4). B,C) Peak TER reduction in response to γC (top) was attenuated by FAK knockdown with both 
(B) siFAK(1) and (C) siFAK(2) siRNA duplex pools (n = 4). Representative blots (bottom) confirm knockdown. D-F) similar effects of gene silencing 
with siSrc(1) and siSrc(2) (n = 4) on ECIS tracings, peak TER and representative blots (bottom) to confirm knockdown. G) RLMVECs treated with siFAK 
(1) displayed a significant reduction of γC-induced Src phosphorylation (Y416) relative to the cells treated with control siRNA, (n = 4). H) Similarly, the 
cells treated with FAK inhibitor (PF573228, 1 μM) for 30 minutes, prior to 10-minute γC (10 μg/mL) treatment, reduced γC-induced Src 
phosphorylation. TER calculations, blots and average optical densities are representative of four independent experiments, (n = 4). ECIS tracings and bar 
graphs represent the mean ± s.e.m. Groups with the same letter are not significant from each other (p @ 0.05).
https://doi.org/10.1371/journal.pone.0231739.g004 
and Src independently initiate distinct pathways, FAK is responsible for Src activation through 
FAK autophosphorylation on Y397, which creates a binding site for SH2 domain of Src, allow- 
ing Src to autophosphorylate residue Y416 [7, 34, 42]. FAK mediates the association of Src 
with focal adhesions using the SH2 domain [34]. FAK inhibitor Y15 reduced Src phosphoryla- 
tion in colon cancer cells in a dose-dependent manner [43]. Consistent with these reports, our 
current data reports that FAK inhibition or genetic knockdown diminishes γC-induced Src 
phosphorylation, therefore suggesting that FAK is upstream of Src. 
Our study also supports the well-established link that Src plays in endothelial barrier func- 
tion [11, 20, 26, 27]. Src remains in an inactive state through association with the SH2 domain 
and Y527 [44]. Upon activation, Y527 dephosphorylates causing destabilization of the SH2, 
SH3 and other kinase domains, and Y416 autophosphorylation [7, 44]. γC-induced barrier 
leakage involves phosphorylation of Src Y416, a critical phosphorylation site also known to be 
responsible for mediating thrombin barrier dysfunction [45]. Activated neutrophils also stim- 
ulate Src activity through phosphorylation of residue Y416, thus mediating barrier dysfunction 
in human endothelial cells and hyperpermeability in porcine coronary venules [20]. While our 
data supported that γC increases tyr416 phosphorylation of Src, an event known to upregulate 
Src activity by using a phospho-specific antibody against Src, the same antibody also recog- 
nizes similar phosphorylated sites in other Src family kinases such as Yes, Fyn and Lyn [46, 
47]. Therefore, our data do not exclude the potential effect on the endothelial barrier function 
by γC through other Src family kinases. Further experimentation revealed that Src inhibitor 
PP2 attenuated γC-induced albumin hyperpermeability in rat mesenteric microvessels and 
attenuated drop in TER in cultured monolayers. These data supported other studies that dem- 
onstrate improved endothelial barrier function upon treatment with PP2 [16, 27, 33]. Src 
inhibitors protect monolayers from increased permeability through regulation of AJ proteins 
[16, 19, 45]. Junctional protein regulation can be triggered by Src mediated intracellular signal- 
ing events [48]. We show that γC-mediated VE-Cadherin phosphorylation in a Src-dependent 
manner, supporting the established role that Src serves as a key element regulating junctional 
disorganization in response to many inflammatory mediators. 
The integrity of the endothelial barrier is largely dependent on AJ at cell-cell contact and 
many inflammatory mediators promote vascular hyperpermeability through AJ signaling 
pathways [20, 31, 36]. Our results indicate that γC promotes phosphorylation of VE-Cadherin 
at Y658 in a dose-dependent manner, followed by subsequent barrier dysfunction through AJs 
dissociation, which are regulated by FAK and Src activation. Consistent with our findings, 
other groups have also reported that increase in VE-Cadherin phosphorylation leads to AJ 
opening and barrier dysfunction [19, 31 49]. Integrin antagonist cilengitide induces VE-Cad- 
herin phosphorylation at Y658 and Src inhibition attenuates phosphorylation at this residue 
and reduces cilengitide-induced disappearance of VE-Cadherin at the cell-cell contacts [50]. 
Additional studies have supported the role of FAK-mediated AJ dissociation [8, 39]. In our 
study, siRNA knockdown or pharmacological inhibition of FAK or Src significantly improved 
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Fig 5. FAK and Src inhibition rescues γC induced barrier dysfunction through Adherens Junction (AJ) dissociation. RLMVECs were grown to 70% confluency, 
transfected with control, FAK, or Src siRNA, and then treated 48 hours post-transfection with γC (10 μg/mL) or vehicle control for 10 minutes followed by 
immunoprecipitation of VE-cad and blotting against β-Catenin (A) or by immunoprecipitation of β-Catenin and blotting against VE-cad (B). Densitometry analysis of 
these data indicates that γC resulted in a significant reduction in VE-cad and β-cat co-immunoprecipitation, which was attenuated by both FAK and Src siRNA- 
mediated silencing (n = 3) C) RLMVECs were treated with indicated concentration of γC for 10 minutes. Cells were lysed and analyzed for VE-cad phosphorylation 
(pY658). γC induced a concentration dependent increase in phosphorylation of VE-cad Y658, (n = 4). D) RLMVECs were treated with vehicle control or FAK inhibitor 
(PF573228, 1μM) for 30 minutes, prior to γC (10 μg/mL) for 10 minutes, and then lysed and analyzed for pVE-cad Y658. FAK inhibition reduced the increased 
phosphorylation of VE-Cadherin by γC, (n = 4). E) RLMVECs were treated with vehicle control or Src inhibitor (PP2, 10μM) for 30 minutes prior to γC (10 μg/mL) for 
10 minutes, and then lysed and analyzed for pVE-cad Y658. Src inhibition attenuated γC-induced VE-cad (Y658) phosphorylation (n = 4). Bar graphs represent the 
mean ± s.e.m. Groups with the same letter are not significant from each other (p @ 0.05).
https://doi.org/10.1371/journal.pone.0231739.g005 
AJ protein disorganization in response to γC and attenuated vascular hyperpermeability in 
γC-treated lung and mesenteric microvasculature. Downregulation of FAK by siRNA in cul- 
tured cells attenuated the increase of VE-Cadherin phosphorylation at Y658 by γC. FAK 
appears to modulate AJ activity by facilitating the transportation of c-Src to AJs, where Src 
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Fig 6. FAK and Src inhibition reduces γC-induced junctional protein disorganization. RLMVECs were grown to confluence on glass bottom microwells and pre- 
treated with vehicle control, FAK (PF573228, 1μM), or Src inhibitor (PP2, 10 μM), followed by γC (10 μg/mL) treatment for 10 minutes prior to immunofluorescence 
staining for VE-Cadherin and β-Catenin, and imaging with confocal microscopy. A) Representative confocal micrographs of RLMVECs stained for VE-cad and β-cat 
indicated γC-induced AJ rearrangement and dissociation, which were reversed with FAK and/or Src inhibition. B) Colocalization analysis was used as an indicator of 
VE-cad and β-cat coupling at cell-cell borders and Pearson’s correlation (R) coefficients were quantified per cell across three independent experiments. Results are 
presented as scatter dot plots with bars, where individual dots represent Pearson’s R/cell and bars indicate the mean across experiments. C-E) Using maximum 
projections for VE-cad on the same images the total surface area of gap formations (D) and the number of discontinuous labeling at cell-cell borders (E) were quantified. 
C) The representative grey scale images of VE-cad are shown to demonstrate how pixel-to-pixel tracings of positive VE-cad (red lines) were done, and at areas where the 
tracing was negative for VE-cad a perpendicular green line was used to indicate a ‘disruption’. The representative gaps are shown by continuous green lines encircling 
the borders of a gap area. The scatter dot plots and bars indicate the number of cells measured in micrographs over 3 independent experiments. Bars graphs represent 
the mean ± s.e.m. (n = 3). Groups with the same letter are not significant from each other (p @ 0.05).
https://doi.org/10.1371/journal.pone.0231739.g006 
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Fig 7. FAK and Src inhibition reduces γC-induced RhoA activity and stress fiber formation. RLMVECs were grown to confluence on glass bottom microwells and 
pre-treated with vehicle control, FAK (PF573228, 1μM), or Src inhibitor (PP2, 10μM), followed by γC (10 μg/mL) treatment for 10 minutes prior to F-actin labeling with 
AF 647-conjugated phalloidin. Representative images obtained using confocal microscopy (A). Arrows show heavy areas of γC-induced stress fiber formation and 
reduction of stress fibers by FAK and Src inhibition. B,C) Quantification of total F-actin intensity per micrograph (B) and stress fiber formation per cell (C). Data 
displayed as scatter dot plots with bars indicating the mean. RLMVECs were grown to confluence and pre-treated with (D) FAK inhibitor (PF573228, 1μM), or (E) Src 
inhibitor (PP2, 10μM) prior to γC (10 μg/mL) treatment for 10 minutes. Cells were lysed and analyzed for active RhoA (GTP Rho) (n = 4). F) RLMVECs were grown to 
70% confluency, transfected with control, FAK, or Src siRNA, and then treated 48 hours post-transfection with γC (10 μg/mL) or vehicle control for 10 minutes followed 
by pull-down assay and immunoblotting for the detection of active RhoA (GTP Rho). siRNA knockdown of FAK and Src reduced γC-induced Rho activation by 
approximately 50% when compared to control siRNA. Blots and average optical densities are representative of three independent experiments, (n = 3). Groups with the 
same letter are not significant from each other (p @ 0.05).
https://doi.org/10.1371/journal.pone.0231739.g007 
induces VE-Cadherin phosphorylation [39]. We demonstrate that γC-induced FAK activity 
promotes Src phosphorylation at residue Y416. While in support of our findings, it has been 
reported that FAK is capable of regulating the activation of Src [18, 34, 42], others have shown 
the activation of FAK by Src [16, 17]. This suggests that the dynamic relationship between 
FAK and Src may vary based on the stimulus involved and the dynamic state of the endothe- 
lium. It is possible that the two tyrosine kinases interact through a feedback mechanism, since 
different residues require the activation of the other. 
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Over the past decades, RhoA pathway has been implicated in endothelial hyperpermeability 
[6, 9, 21, 25], and Rho-GTP pull down assays in our previous study supported γC promoting 
barrier dysfunction through RhoA activation and MLC phosphorylation [5]. RhoA is known 
to play a direct role in cytoskeletal actin remodeling and F-actin polymerization [6, 25, 36, 37] 
and formation of F-actin fibers can lead to cytoskeletal reorganization and cell contraction 
causing subsequent gap formation, which allows blood components (fluid and plasma protein) 
to leak into interstitial tissue [37]. Activated-neutrophils have been shown to increase endothe- 
lial permeability through RhoA pathway activation, stress fiber formation, and intercellular 
gap formation [24, 25]. Our results indicate that γC elicits similar gap formation through F- 
actin reorganization and activation of the RhoA pathway. Evidence suggests a crosstalk 
between FAK/Src signaling and RhoA during paracellular permeability [21, 38, 51]. Src phos- 
phorylation is necessary for functional formation of integrin-dependent focal adhesion attach- 
ment to actin stress fibers in fibroblasts [52], and FAK induces RhoA phosphorylation leading 
to gap formation and endothelial barrier dysfunction [51, 53]. We show that either FAK or Src 
inhibition can independently reduce F-actin stress fiber formation and significantly attenuate 
Rho GTP activity induced by γC. 
In summary, we have shown that FAK and Src are implicated in the hyperpermeability 
response to γC. Inhibition of both FAK and Src attenuates γC-mediated Rho activation, AJ dis- 
sociation, F-actin polymerization, and subsequent endothelial barrier dysfunction and micro- 
vascular hyperpermeability, where FAK is an upstream regulator of Src. Our data provide 
experimental evidence supporting the roles of FAK and Src in mediating microvascular hyper- 
permeability elicited by γC. 
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